Predict your next investment

Asset/Investment Management

See what CB Insights has to offer

Investments

10

Portfolio Exits

4

About JGB Management

JGB Management is a New York based asset management firm.

JGB Management Headquarter Location

660 Madison Avenue 21st Floor

New York, New York, 10021,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest JGB Management News

NewAge announces $12M credit facility

Mar 14, 2022

NBEV used this facility to repay in full its existing outstanding loan balance of $10.6M under its 8% senior secured note with JGB Management. The remaining availability on the new facility will be used for general working capital purposes. The new line of credit bears interest at Prime plus 1.75%, and is interest-only until Mar. 2024. "This new credit facility successfully retires the $30M senior secured debt used to fund a portion of the ARIIX acquisition and enhances our liquidity profile," said NBEV interim CEO Ed Brennan. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

JGB Management Investments

10 Investments

JGB Management has made 10 investments. Their latest investment was in Cascadian Therapeutics as part of their PIPE on February 2, 2011.

CBI Logo

JGB Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/11/2011

PIPE

Cascadian Therapeutics

$0.15M

Yes

3/16/2007

PIPE

Cleveland BioLabs

$30.02M

No

9/18/2006

PIPE - II

Advanced Cell Technology

$8.75M

No

9/5/2006

PIPE

Subscribe to see more

$99M

Subscribe to see more

0

1/19/2006

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

0

Date

2/11/2011

3/16/2007

9/18/2006

9/5/2006

1/19/2006

Round

PIPE

PIPE

PIPE - II

PIPE

Unattributed VC - II

Company

Cascadian Therapeutics

Cleveland BioLabs

Advanced Cell Technology

Subscribe to see more

Subscribe to see more

Amount

$0.15M

$30.02M

$8.75M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

JGB Management Portfolio Exits

4 Portfolio Exits

JGB Management has 4 portfolio exits. Their latest portfolio exit was Cascadian Therapeutics on March 09, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/9/2018

Acq - P2P

$99M

4

1/18/2008

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

2/17/2006

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/6/2005

IPO

Subscribe to see more

Subscribe to see more

0

Date

3/9/2018

1/18/2008

2/17/2006

6/6/2005

Exit

Acq - P2P

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

0

10

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.